Ctrl K

AbbVie Inc.

ABBV

Pharmaceutical Preparations

Last filing · Quarter 2 · Jun 30, 2026

Financial Statements Ratios

Export XLSX

Statement

Income Statement Balance Sheet

Period

Annual Quarterly

Order

Unlock 29 quarters

Format

% Change

Rows

USD ($) $ in Millions	Jun 30, 2026	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Sep 30, 2022
Current assets
Cash and equivalents	$ 6,569	$ 9,391	$ 5,629	$ 6,467	$ 5,175	$ 7,257	$ 13,130	$ 18,067	$ 13,287	$ 8,759	$ 6,711	$ 11,832
Restricted cash	-	-	-	-	-	-	-	-	-	-	-	-
Short-term investments	-	-	42	0	1	28	27	2	3	7	11	47
Accounts receivable, net	13,824	12,479	12,769	12,637	12,477	11,472	11,724	11,949	11,412	11,491	11,473	10,743
Inventories	5,127	5,049	4,938	4,960	4,526	4,450	4,218	4,245	3,981	4,055	3,833	3,172
Prepaid expenses and other	8,149	6,610	5,161	5,197	5,496	4,578	4,717	4,608	4,541	4,540	4,460	4,570
Income tax receivable	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets	33,669	33,529	28,539	29,261	27,675	27,785	33,816	38,871	33,224	28,852	26,488	30,364
Investments	266	268	291	310	287	267	272	305	275	288	257	235
Property and equipment, net	5,796	5,687	5,483	5,283	5,237	5,141	5,023	4,980	4,934	4,943	4,931	4,893
Intangible assets, net	49,139	50,873	54,315	57,031	58,489	66,646	60,243	62,225	58,603	62,862	64,848	68,725
Goodwill	35,519	35,570	35,626	35,638	35,285	35,295	33,386	33,426	32,091	32,224	32,220	31,726
Other assets	10,726	10,536	9,644	9,659	9,192	8,288	9,197	9,067	7,094	6,198	5,800	5,382
Total assets	135,115	136,463	133,898	137,182	136,165	143,422	141,937	148,874	136,221	135,367	134,544	141,325
Liabilities and Equity (Deficit)
Current liabilities
Short-term borrowings	0	0	3,790	5,556	1,593	-	-	3	2	0	1	10
Current portion of long-term debt	8,341	8,326	1,982	1,966	3,769	12,570	12,586	10,193	5,113	5,203	2,800	9,197
Accounts payable and accrued liabilities	33,301	33,774	33,619	32,245	31,041	30,492	29,329	31,326	29,658	27,036	24,789	23,505
Total current liabilities	41,642	42,100	39,391	39,767	36,403	43,062	41,915	41,522	34,773	32,239	27,590	32,712
Long-term debt	62,481	64,532	62,971	62,959	64,527	58,509	58,048	63,805	55,631	55,812	59,292	60,399
Deferred income taxes	2,277	2,332	2,480	2,554	2,582	2,749	2,726	2,722	2,044	2,124	2,110	1,972
Other long-term liabilities	34,603	34,111	31,655	32,040	31,191	33,031	32,427	32,778	31,644	32,294	32,249	30,215
Stockholders' equity (deficit)
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,844,174,521 shares issued as of June 30, 2026 and 1,838,678,628 as of December 31, 2025	18	18	18	18	18	18	18	18	18	18	18	18
Common stock held in treasury, at cost, 77,105,240 shares as of June 30, 2026 and 70,802,593 as of December 31, 2025	10,618	10,611	9,143	9,147	9,137	7,848	7,838	7,829	6,525	6,528	6,524	4,590
Additional paid-in capital	23,156	22,962	22,291	21,987	21,808	21,160	20,879	20,656	20,021	19,839	19,619	19,056
Accumulated deficit	(17,333)	(17,872)	(14,234)	(11,503)	(9,527)	(4,964)	(3,768)	(2,384)	933	1,789	2,393	4,953
Accumulated other comprehensive loss	(1,158)	(1,153)	(1,574)	(1,538)	(1,742)	(2,334)	(2,513)	(2,454)	(2,353)	(2,252)	(2,232)	(3,443)
Total stockholders' deficit	(5,935)	(6,656)	(2,642)	(183)	1,420	6,032	6,778	8,007	12,094	12,866	13,274	15,994
Noncontrolling interest	47	44	43	45	42	39	43	40	35	32	29	33
Total deficit	(5,888)	(6,612)	(2,599)	(138)	1,462	6,071	6,821	8,047	12,129	12,898	13,303	16,027
Total liabilities and equity (deficit)	$ 135,115	$ 136,463	$ 133,898	$ 137,182	$ 136,165	$ 143,422	$ 141,937	$ 148,874	$ 136,221	$ 135,367	$ 134,544	$ 141,325
Statement [Table]